Replication of attenuated poliovirus strains results in their partial deattenuation. Recently we identified mutations accumulating in the Sabin 1 poliovirus in cell cultures. Here we report genetic changes occurring in this virus during replication in the central nervous system (CNS) of monkeys. Viruses isolated from different parts of the CNS of rhesus monkeys (inoculated into the spinal cord) were screened for sequence heterogeneities and newly identified mutations were independently confirmed and quantified using mutant analysis by PCR and restriction enzyme cleavage (MAPREC). All consistently accumulating mutations identified in this study ,vere located in untranslated regions: GU -~ AU or GU -~ GC substitution at a complementary pair formed by nucleotides 480 and 525, U -~ C substitution at nucleotide 612, and GU -~ AU or GU~GC substitution of a base pair formed by the nucleotides 7427/7441 immediately preceding the poly(A) tract. All these mutations except one (7427) were previously identified in cell culture passages or stool isolates from vaccinees. Sequencing of 11 CNS isolates also identified a few random silent mutations that accumulated as neutral 'passengers', passively coselected with genuinely selectable mutations present on the same RNA molecule. One isolate also contained the wild-type base at nucleotide 2741 (Ala 88 ~ Thr in VP1).
Introduction
The high mutation rates inherent in viral RNA replication provide a practically unlimited source of variants for the selection of virus particles with the highest replicative capacity under given growth conditions. It has been demonstrated that replication of attenuated Sabin strains ofpoliovirus both in vivo and in vitro results in gradual quantitative changes in attenuation markers such as reduced replicative capacity at an increased temperature (rct40) or at a reduced concentration of sodium bicarbonate (d-marker) and more importantly, increased neurovirulence in monkeys (Benyesh-Melnick & Melnick, 1959; Sabin, 1957 Sabin, , 1961 . Because of these changes, every batch of oral poliovirus vaccine (OPV) must be safety-tested in monkeys before it can be released for use in humans (WHO, 1990) . Monkey tests are very expensive and require sacrificing primates, so * Author for correspondence. Fax + 1 301 594 6530. e-mail CHUMAKOV@HELIX.NIH.GOV the development of alternative safety tests to directly measure the content of neurovirulent mutations in vaccine lots directly is an important objective. In the past decade significant progress has been made in identifying the molecular determinants of poliovirus attenuation and neurovirulence (see Minor et al., 1993 ; Macadam et al., 1994 for reviews) . Studies with recombinants between revertant strains of poliovirus isolated from vaccine recipients and attenuated strains revealed several point mutations responsible for increased monkey neurovirulence in each of the three types of poliovirus. Using a new sensitive method (mutant analysis by PCR and restriction enzyme cleavage; MAPREC) we demonstrated that every batch of type 30PV contained some detectable amount of 472-C revertant and batches that failed the monkey neurovirulence test (MNVT) had higher contents of this revertant (Chumakov et al., 1991) . MAPREC had good predictive power, which suggested the possibility of replacing, or at least supplementing, the MNVT with a simpler molecular procedure (Rezapkin et al., 1994) . This suggests that a very limited number of genomic sites need to be tested by MAPREC to monitor the consistency of vaccine production.
Methods
Virus isolation. Juvenile rhesus monkeys were inoculated in the lumbar cord with 0-1 ml of the United States neurovirulence reference of type 10PV, NA-4 (6.~6-5 log10 TCIDs0 per monkey) as described elsewhere (WHO, 1990; US Code of Federal Regulations, Title 21, Part 630.16, 1994) . Five monkeys were sacrificed 8 days post-inoculation; segments of lumbar, thoracic and cervical parts of the spinal cord and the lower part of the medulla were frozen at -70 °C. We also isolated virus from the lower thoracic areas of the spinal cords of 42 monkeys sacrificed on day 17 as a part of the routine MNVT of OPV lots. All procedures on monkeys were performed under general anaesthesia as specified in protocols approved by the Institutional Animal Care and Use Committee, CBER. Homogenates were prepared in Eagle's MEM for virus isolation in HEp2 cells. In most cases CPE appeared 2~4 days after infection. Cultures were frozen and thawed three times, clarified by low-speed centrifugation and the supernatant fluid was used for further analysis.
Mutation analysis' and sequencing. Procedures for RNA isolation, cDNA synthesis, PCR and MAPREC were as described before (Chumakov et al., 1991 (Chumakov et al., , 1992 Lu et al., 1993) . Screening for mutations was performed either by PCR-based sequence heterogeneity assay (SHA) (Rezapkin et al., 1994) , or by fluorescent dye-labelled primer sequencing using an automated DNA sequencer (Model 370A; Applied BioSystems). For dye-labelled primer sequencing, viral cDNA was amplified by PCR to make 13 overlapping DNA fragments using primers Y-tailed with universal forward or reverse M13 sequence. The cycle sequencing reaction mixtures contained ddNTP, fluorescent M 13 or -21M13 primer, appropriate buffer and DNA template in a total volume of 5 pl for A and C, and 10 gl for G and T reactions. After 15 cycles consisting of denaturation for 15 s at 95 °C, annealing for 5 s at 55 °C and extension for 1 min at 70 °C followed by 15 additional cycles consisting of 15 s at 95 °C and 1 min at 70 °C, reaction products for each ddNTP were pooled and analysed by polyacrylamide gel electrophoresis. All newly identified mutations, as well as those previously shown to accumulate in cell cultures, were quantified by MAPREC. Primers and restriction enzymes used for previously identified mutations have been described (Rezapkin et al., 1994) and those for newly identified mutations are listed in Table 1 . MAPREC assay for the position 7427 U ~ C mutation used a template extension oligonucleotide, similar to that previously described for the position 7441 G ---, A mutation (Rezapkin et al., 1994) . in the PCR product containing 480-A and 480-G, respectively, and ScrFI and BspEI in the PCR product with 525-C and 525-T. Therefore two double digestions of the PCR product with DdeI/BspEI and ScrFI/PflMI allowed us to discriminate all four possible nucleotide combinations at this complementary region (Fig. 1) .
Simultaneous test for mutations at nucleotides

Results
A total of 20 strains were isolated from 20 samples of medulla, cervical, thoracic and lumbar segments of the CNS of five monkeys sacrificed 8 days post-inoculation and five strains from 42 CNS samples taken on day 17 post-inoculation. All the isolates were analysed by M A P R E C for the presence of mutations previously identified in cell culture passages of the Sabin 1 virus (Rezapkin et al., 1994; Christodoulou et al., 1990) . The isolates from all monkeys except one contained either a reversion to wild-type 480-A or a 525-C mutation, both of which were previously detected in stool isolates and in cell culture passages and shown to increase monkey neurovirulence. Some isolates also contained a G ~ A reversion in the 3'-terminal nucleotide 7441, which immediately precedes the poly(A) tract. An additional U C mutation at nucleotide 612 of the Y-untranslated region (Rezapkin et al., 1994) was found in several day 8 and day 17 CNS isolates, in some cases reaching high levels (more than 30-60 %).
To identify other mutations that might have accumulated in the virus genome during replication in the CNS of monkeys, we screened R N A of five virus isolates from day 8 samples by SHA -a technique that earlier proved to be very sensitive, in some cases able to detect heterogeneities of less than 1% (Rezapkin et al., 1994) . In addition we sequenced five isolates from day 17 and one additional isolate from day 8 by automated sequencer. Besides the mutations mentioned above, we found only a few other mutations, only one of which ( 7 4 2 7 -U~C ) accumulated in several virus isolates obtained from three monkeys (Table 2) .
In addition to the consistent mutations listed in Table  2 , some other mutations were observed in single isolates. Eight of them were silent (at nucleotides 781, 2992, 3391, 3895, 3919, 3991, 5338 and 6973) and one missense mutation (2741-G ~ A) was found in an isolate from a day 17 monkey, and changed Ala ss in VP1 to a wild-type Thr (Table 3) . Screening of all other viral isolates from monkeys and of isolates from cell culture passages previously reported (Rezapkin et al., 1994) found none that contained this reversion. To determine whether this mutation gives the virus any replicative advantage in cell culture, we passaged a virus sample containing about 40 % of 2741-A in HEp2 cells at 37 °C and 38.5 °C. Fig.  3 shows that at 38-5 °C 2741-A increased, whereas at 37 °C it gradually disappeared, suggesting that it is a temperature-sensitive (ts) determinant.
The consistent occurrence of a mutation in more than one virus sample suggests that it may provide a selective advantage to the virus. Mutations present in single isolates, especially silent mutations, may be incidental and simply result from a 'passenger' effect, i.e. coselection driven by another advantageous mutation occurring by chance in the same molecule of viral RNA. To address this hypothesis, we isolated and analysed by M A P R E C 33 plaques from a strain containing about 50 % of a selectable mutation at nucleotide 525 and 50 % of a silent mutation at nucleotide 2992. Analysis of 33 plaque-purified subclones of an isolate from the spinal cord of a monkey 8 days after inoculation with OPV 
* Lesion scores for individual monkey and mean for a group of 12 monkeys are presented. Nucleotides that were different from the Sabin 1 sequence are shown.
showed that mutations at nucleotides 525 and 2992 were always found together (11 subclones had the original sequence and 22 the mutations at both these sites). This indicates that the 2992-U--, C mutation was a neutral 'passenger' increasing only because it occurred on the same molecule as the mutation at nucleotide 525.
The above example demonstrates that mutant accumulation depends on their distribution among individual molecules of viral RNA. combination can be found in a population of partially reverted virus containing both 480-A and 525-C mutations, we modified the MAPREC assay to analyse the distribution of these two mutations in the same molecule of virus RNA. Results of a typical analysis of a partially reverted population of the Sabin 1 strain are shown in Fig. 1 . It clearly shows that, in addition to the attenuated G: U configuration, there were about 15 % A: U pairs and 5 % G:C pairs but no A:C pairs. This result agrees with our previous finding that during early passages of the Sabin 1 virus in vitro both mutations accumulated, but at higher passages only one mutation took over, 480-A in AGMK cells and 525-C in Vero cells (Rezapkin et al., 1994) . A second example, the in vitro selection of the 7427-C mutation, illustrates an indirect influence of mutations on each other determined by populational effects. This mutation was observed only in isolates from the CNS of monkeys and never in passages in cell cultures, suggesting that it confers no strong selective advantage to the virus in vitro. However, passaging in Vero cells of two CNS isolates, each containing some 7427-C reversion showed that its content increased in one (Fig. 3 a) , whereas in the other it gradually disappeared (Fig. 3 b) . Plaque analysis of these viruses showed that in the first virus isolate, 7427-C was always found on the same RNA with the strongly selectable 480-A mutation, whereas in the second isolate some viral particles contained 7427-C but no selectable mutations whereas other particles contained 525-C but no 7427-C. This pattern of distribution suggests that in the second isolate 7427-C was selected in the CNS independently of 525-C, but on passage in cell culture 7427-C decreased due to the poor relative fitness of 525-U on the same molecule. Therefore itis likely that in the first case 7427-C accumulation was driven by selection of the helper 480-A mutation, and in the second case 7427-C was eliminated by competition with virus containing the strongly selectable 525-C.
Discussion
The low fidelity of viral RNA replication results in continuous generation of a wide variety of virus variants with genomes that differ from the consensus sequence by one or more mutations. With characteristic mutation rates of 10-~-10 -4 per nucleotide per round of replication (Ward et al., 1988; Ward & Flanegan, 1992) and genome size of about 7400 nucleotides, most molecules of poliovirus RNA are predicted to contain at least one mutation after just a few rounds of virus replication. Such mixtures of slightly different viral particles have been described as quasispecies (Holland et al., 1982; Domingo et al., 1985) . This 'fuzzy' nature of RNA viruses profoundly affects their biology and evolution and probably plays an equally important role in such practical issues as pathogenesis and the neurovirulence safety of live vaccines.
During the past few years we have demonstrated that even a small increase from 0.8 % to 1.2 % in content of 472-C mutations in type 30PV leads to a detectable increase of neurovirulence in monkeys, resulting in failure of a vaccine batch in the MNVT (Chumakov et al., 1991 . Similarly, an excessive content of certain mutations in OPV of types 1 and 2 also appeared to increase levels of neurovirulence in monkeys Taffs et al., 1995) . Therefore these small differences in mutational composition of virus stocks are clearly related to their biological properties.
The MAPREC assay (Chumakov et al., 1991) provided us with a tool for the identification and quantification of subtle genetic changes appearing in the Sabin strains of OPV during their passaging both in cell cultures and in vivo. Genetic changes responsible for causing the deattenuation of vaccine strains were documented in early studies of OPV (Benyesh-Melnick & Melnick, 1959; Sabin, 1957 Sabin, , 1961 . Extensive screening of cell culture passages of all three types of attenuated poliovirus detected relatively small numbers of mutations that consistently accumulated during in vitro cultivation, with a profile specific for the cell substrate and conditions used to propagate the virus (Rezapkin et al., 1994 Taffs et al., 1995) . In the present study we performed similar screening for mutations in the Sabin 1 poliovirus after propagation in the CNS of monkeys, assuming that any consistently accumulating mutation must provide the virus with a selective advantage for replication in neural tissue and possibly a partial reversion of the attenuated strain to neurovirulence.
A striking result of this study with type 10PV is that we found only one consistently accumulating mutation in addition to a few that were previously identified in our studies in vitro. This new mutation, a U ~ C transition at nucleotide 7427, is complementary to the T-ultimate nucleotide 7441 (Pilipenko et al., 1992a) , and probably stabilizes the same 3'-terminal hairpin of the viral RNA. A mutation at nucleotide 7441, reverting to the base of the wild-type OPV 1 progenitor Mahoney strain, was previously found to accumulate in cell culture passages, especially at higher temperatures (Christodoulou et al., 1990; Rezapkin et al., 1994) . The role of both mutations at nucleotides 7427 and 7441 in viral replication, as well as in neurovirulence of poliovirus type 1 is currently being studied in our laboratory.
Another consistently accumulating mutation, located at nucleotide 612 of the 5'-UTR, was previously found in cell culture passages only at a very low level (2 % or less; Rezapkin et al., 1994) . Its potential significance was confirmed by finding relatively high levels of 612-C in several isolates from four monkeys. Most isolates with the 612-C mutation were from monkeys sacrificed on day 17, suggesting that this mutation tends to accumulate in the late phase of experimental infection. Nucleotide 612 is complementary to A in the indispensable AUG triplet in the B-box of the IRES element (Pilipenko et al., 1992b) . This suggests that the 612-U ~ C mutation may influence initiation of viral protein synthesis, a step that influenced viral neurovirulence in other cases.
Another remarkable observation is that all mutations consistently accumulating in the Sabin 1 poliovirus, propagated both in vitro and in vivo, are located in 5'-and 3'-UTRs. Perhaps the most important of these mutations are at nucleotides 480 and 525 that form a base pair in the F domain (domain VI) of viral RNA within the IRES element (Skinner et al., 1989) . During replication of the Sabin 1 virus in the CNS of monkeys reversion occurred predominantly at nucleotide 480, although in one monkey we observed reversion at nucleotide 525.
Simultaneous quantification of mutations at nucleotides 480 and 525 showed that they never occurred on the same RNA molecule, suggesting that the unstable A:C configuration in this RNA domain must be lethal for the virus. In contrast, substitution of the weak G:U pair present in the attenuated strain by either an A:U or a G:C pair increased fitness of the virus both in cell cultures and in the CNS resulting in deattenuation.
Isolates from one monkey sacrificed on day 8 had no detectable mutations. It seems unlikely that the virus isolated from the medulla, far from the lumbar inoculation site, would come from the original inoculum. It seems more likely that the Sabin 1 virus replicated in the CNS without accumulating any mutations, demonstrating that a fully attenuated poliovirus replicated and spread up the CNS when inoculated directly into the spinal cord. The extent of virus replication probably correlates with the histological lesions in the CNS. This is illustrated by the observation that histological lesion scores in monkeys sacrificed on day 17 post-inoculation from which virus was isolated (only five samples of 42 cultured) were among the highest in this group.
In addition to consistently accumulating mutations, there were others found in single isolates only. All except one were silent mutations (see below). A direct back mutation at nucleotide 2741 (changing Ala to Thr in amino acid 88 of VP1) was observed in one isolate from a day 17 post-inoculation monkey. It is noteworthy that a G ~ U mutation at the same site (Ala--* Ser) was previously reported in the Sabin 1 virus adapted to replication at 39 °C in vitro (Christodoulou et al., 1990) and a mutation at a neighbouring site occurred upon passaging of type 3 poliovirus in cell cultures . Our data suggest that the 2741-A mutation is a ts determinant of the virus, since it was selected in cell culture at 38.5 °C but not at 37 °C, which agrees with a recent report by Bouchard et al. (1995) . The role of 2741-A in neurovirulence of the poliovirus type 1 strain for monkeys remains to be established; however, it probably poses no threat to the safety of OPV, since it was selected against under conditions of vaccine production and was never found in any of the type 10PV batches tested (Rezapkin et al., 1994) .
Diversity of RNA virus populations, and of poliovirus in particular, has been recognized for a long time (Sabin, 1955) . The concept of a quasispecies, proposed to describe the properties and evolution of RNA virus populations (Holland et al., 1982; Domingo et al., 1985) explains many aspects of poliovirus biology and is important in addressing such practical issues as safety and quality control of OPV (Chumakov et al., 1991 . Quantification of sequence heterogeneities by MAPREC provided a tool for direct studies of dynamics and fine structure of populations of RNA viruses and enabled us to examine 'snapshots' of viral quasispecies and determine mutation profiles of individual virus stocks. In this communication we have further demonstrated the usefulness of this approach for the identification of the potential functional role (or lack thereof) of individual mutations. Studying patterns of accumulation and disappearance of a reversion at nucleotide 2741 in cell cultures at different temperatures demonstrated its temperature-dependence which may help to identify its role. We also observed that silent mutations consistently accumulated during passaging of all three types of polioviruses in cell cultures (Rezapkin et al., 1994 Taffs et al., 1995) . Here we show that at least some of these silent mutations are neutral 'passengers', co-selected because of their fortuitous association in the same viral RNA molecule with some other genuinely advantageous mutations increasing fitness of the virus. On the other hand, when two selectable mutations occur on different molecules of RNA in the same population, the fitter mutation outcompetes the other, as observed for mutations at nucleotides 525 and 7427. Therefore, accumulation of a mutant does not necessarily imply that it confers a selective advantage, and selection of virus variants may often result in accumulation of incidental mutations. Such indirect interactions between mutations in RNA virus populations illustrate the complexity of processes occurring during microevolution of quasispecies. This complexity has implications for live vaccines, since sequence heterogeneity of a vaccine virus creates potential for unpredictable passive selection of random passenger mutations, some of which may possess undesirable properties. Genetic refinement of live vaccines by altering sites where mutations consistently accumulate (even if the mutations themselves are not harmful) might stabilize the rest of genome and help to inhibit the emergence of incidental mutations.
In conclusion, this study completes our screening of the type 1 poliovirus genome for unstable genomic sites both in vitro and in vivo. We found that the number of important sites at which mutations accumulated is very small. We suggest that quantitative MAPREC assays be used to monitor the consistency of OPV production and that they might eventually replace the costly, cumbersome and intrinsically variable monkey neurovirulence test with a simple and reliable molecular procedure.
